You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 130 No. 3, March 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Molecular Medicine
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Tuberous Sclerosis

David J. Kwiatkowski, MD; M. Priscilla Short, MD

Arch Dermatol. 1994;130(3):348-354.


Abstract

Background and Design
Tuberous sclerosis (TS) is a genetic disease with prominent cutaneous and brain involvement whose clinical and molecular genetics are reviewed.

Observations
Tuberous sclerosis is a systemic disorder (incidence one in 10 000) characterized by benign growths (hamartias and hamartomas) in multiple organ systems. Involvement of the brain can result in persistent seizures and mental retardation; skin involvement includes facial angiofibromas, subungual fibromas, hypomelanotic macules, forehead fibrous plaques, and Shagreen's patches. Approximately 60% of TS occurs as apparent sporadic cases. In families, it has autosomal dominant inheritance with high penetrance (approximately 95%), with careful clinical and radiologic evaluation. Genetic linkage analysis indicates that about half of all TS families show linkage to chromosome 9q34, and about half to chromosome 16p13. There are no distinguishing features in the two groups of families showing linkage to the two genomic regions, nor strong evidence for a third causative gene. Positional cloning efforts for both chromosomal regions have limited the region containing the gene to about 1 to 2 million bases.

Conclusions
Identification of the two TS genes should illuminate the pathogenesis of TS and provide opportunities for genetic counseling, prenatal diagnosis, and therapeutic intervention.

(Arch Dermatol. 1994;130:348-354)



Author Affiliations

From the Division of Experimental Medicine, Brigham and Women's Hospital, Boston, Mass, and the Department of Neurology, Massachusetts General Hospital, Boston.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review
Dworakowska and Grossman
Endocr Relat Cancer 2009;16:45-58.
ABSTRACT | FULL TEXT  

A Defect in Protein Farnesylation Suppresses a Loss of Schizosaccharomyces pombe tsc2+, a Homolog of the Human Gene Predisposing to Tuberous Sclerosis Complex
Nakase et al.
Genetics 2006;173:569-578.
ABSTRACT | FULL TEXT  

Aggressive Retinal Astrocytomas in 4 Patients With Tuberous Sclerosis Complex
Shields et al.
Arch Ophthalmol 2005;123:856-863.
FULL TEXT  

An unusual cause of abdominal pain
Postgrad. Med. J. 2003;79:665-665.
FULL TEXT  

Role of the Tsc1-Tsc2 Complex in Signaling and Transport Across the Cell Membrane in the Fission Yeast Schizosaccharomyces pombe
Matsumoto et al.
Genetics 2002;161:1053-1063.
ABSTRACT | FULL TEXT  

Achalasia in a Child with Tuberous Sclerosis Complex
Khan et al.
CLIN PEDIATR 2002;41:68-69.
 

Radiological Case of the Month
Jalou et al.
Arch Pediatr Adolesc Med 2001;155:89-90.
FULL TEXT  

Hamartomas of the Iris and Ciliary Epithelium in Tuberous Sclerosis Complex
Eagle et al.
Arch Ophthalmol 2000;118:711-715.
ABSTRACT | FULL TEXT  

Nuclear Receptor Coregulators: Cellular and Molecular Biology
McKenna et al.
Endocr. Rev. 1999;20:321-344.
ABSTRACT | FULL TEXT  

Mosaicism in Tuberous Sclerosis as a Potential Cause of the Failure of Molecular Diagnosis
Kwiatkowska et al.
NEJM 1999;340:703-707.
FULL TEXT  

Tuberous Sclerosis Gene 2 Product Modulates Transcription Mediated by Steroid Hormone Receptor Family Members
Henry et al.
J. Biol. Chem. 1998;273:20535-20539.
ABSTRACT | FULL TEXT  

Clustered Angiofibromas on the Ear of a Patient With Neurofibromatosis Type 2
Jaffe et al.
Arch Dermatol 1998;134:760-761.
FULL TEXT  

Multiple Facial Angiofibromas and Collagenomas in Patients With Multiple Endocrine Neoplasia Type 1
Darling et al.
Arch Dermatol 1997;133:853-857.
ABSTRACT  

Evolution of Cardiac Rhabdomyoma in Tuberous Sclerosis Complex
Dimario et al.
CLIN PEDIATR 1996;35:615-619.
ABSTRACT  

The Significance of a Single Periungual Fibroma: Report of Seven Cases
Zeller et al.
Arch Dermatol 1995;131:1465-1466.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.